Physician profile
Kari A Thomas
NPI 1073606505
$3,459.34
in general payments reported to CMS, 2019-2025
42 companies · $841 in 2025
The $841 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $202 · 2022: $633 · 2023: $779 · 2024: $1,003 · 2025: $841.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,608 · Education: $15.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,607.55 |
| Education | $15.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $526.93 | 2023-2025 | |
| Amgen INC. | $430.34 | 2023-2025 | Repatha, Repatha, Tezspire |
| Abbvie INC. | $285.13 | 2021-2025 | |
| Pfizer INC. | $230.10 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $175.86 | 2023-2025 | Verquvo |
| Takeda Pharmaceuticals U.S.A., INC. | $132.28 | 2021-2023 | Entyvio |
| Lexicon Pharmaceuticals, INC. | $119.22 | 2023-2024 | Inpefa |
| E.R. Squibb & Sons, L.L.C. | $110.07 | 2024-2025 | Camzyos |
| Kiniksa Pharmaceuticals International, Plc | $95.64 | 2024 | Arcalyst |
| Harmony Biosciences LLC | $93.45 | 2022 | |
| Melinta Therapeutics, LLC | $85.42 | 2022-2023 | Orbactiv, Kimyrsa, Vabomere |
| Daiichi Sankyo INC. | $84.47 | 2022-2023 | Injectafer |
| Alnylam Pharmaceuticals INC. | $77.69 | 2023-2025 | Amvuttra, Onpattro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.23 | 2023-2025 | Jardiance |
| Edwards Lifesciences Corporation | $72.08 | 2024 | Sapien 3 Ultra Resilia |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kari Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.